Navigation Links
New ACO Reinsurance Program Launched by Star Line Group, U.S. Advisors and Ascendent Care
Date:11/8/2011

MINNEAPOLIS, Nov. 8, 2011 /PRNewswire/ -- Star Line Group, U.S. Advisors and Ascendent Care, announced today a new reinsurance program in response to the final regulations published recently by CMS for the Medicare ACO Shared Savings Program.

"We recognize the unique requirements of organizations that want to participate in the ACO Shared Savings Program and their need to moderate their downside risk in an affordable fashion," notes Robert Tierney, Star Line President.  "We have been tracking this issue from the draft regulations and our team has been working on the development of this new program for a number of months."

The ACO Reinsurance program recognizes the delayed cash flow compared to traditional health care financing mechanisms, as well as other unique aspects of the Shared Savings Program.  It is designed to protect an ACO's capital as they take risk on Medicare members.  

"Our reinsurance program really takes a lot of pressure off the downside risk and the cash flow requirements of the ACO," notes Terry Chesser, President of U.S. Advisors. 

"We have studied the environment closely and believe that we have an ideal program for those ACOs who have the motivation to improve quality and efficiency, yet may not have the deepest balance sheets and would otherwise not be able to take advantage of the Track 2 profit sharing rewards,"  explains Dan Johnson, Star Line Vice President.  

Mike Barrett, CEO of Ascendent Care, further adds "Ascendent is pleased to be involved in the due diligence review of ACOs under consideration for reinsurance, as well as the ongoing reporting and monitoring activities.  It is clear that this will expand the number of organizations that can step up to meet the mission and goals of the Medicare ACO Shared Savings Progr
'/>"/>

SOURCE Star Line Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin™
2. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
3. "PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched
4. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
5. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
6. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
7. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
8. Novo Nordisk and Atlanta Area Organizations Partner on Diabetes Education Programs
9. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
10. BD Biosciences Announces Winners of Research Grant Program
11. University of Houston receives NSF grant for high school teachers program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) ... Outlook 2015: New Therapy Ventures Pave the Way for ... All biotech companies - Gilead (GILD), Amgen (AMGN), Biogen ... given a positive return and hence increased the interest ... select therapy/niche indication where the high treatment cost justifies ...
(Date:3/5/2015)... The next implants made from the PEEK-OPTIMA® ... (European) approval. The CE mark is necessary for distributing ... the European Union. Following the Class IIb approval route, ... supplied by the Turkey-based company Osimplant for the treatment ... Expandable Bladed HA PEEK Cage line of spinal implants, ...
(Date:3/4/2015)... 4, 2015 In an article published and ... for Health Security review the clinical aspects of diseases ... as bioweapons. The article, "Clinical Management of Potential Bioterrorism-Related ... website of the New England Journal of Medicine ... Toner , and Tom Inglesby—review the clinical management of ...
(Date:3/4/2015)... 2015 USDM Life Sciences , ... sciences industry, hired David Blewitt as Vice ... Compliance Services and Solutions at USDM Life Sciences , ... while maintaining compliance with government regulations worldwide. , ... accomplished life sciences regulatory and IS compliance professional with ...
Breaking Biology Technology:Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 2Invibio’s PEEK-OPTIMA® HA Enhanced Gains Momentum: New Implant Receives European Approval 3Latest Clinical Information On Bioterrorism Threats 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3
... DIEGO, April 14 XIFIN Inc., the ... diagnostic laboratories, announced today that XIFIN,s CEO ... at the Executive War College Conference in ... attendance will be senior executives, laboratory administrators ...
... to begin after markets close at 2:00 p.m. PT (5:00 ... MASI ), the inventor of Pulse CO-Oximetry and Measure-Through ... first quarter 2009 financial results for the period ended April ... 2009.A conference call to review the results will begin at ...
... N.C., April 14 Pharmaceutical Institute (PI), the ... pharmaceutical and biotech industry, today announced the release ... Markets Excellence(TM) . The series was developed ... leaders from 17 large and midsize pharmaceutical and ...
Cached Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 3
(Date:3/2/2015)... 2015   Neurotechnology , a provider of high-precision ... SentiGaze Software Development Kit (SDK). The SentiGaze algorithm ... off-the-shelf webcams to track eye movements and generate heatmaps ... Heatmaps can be used for applications such as analysis ... The SDK can also be used to develop interfaces ...
(Date:2/24/2015)... YORK , Feb. 24, 2015 This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the ... provided for these markets. Market data and analytics are derived ...
(Date:2/24/2015)... DUBLIN , Feb. 24, 2015 Research ... announced the addition of the "Global 2D ... offering. The analysts forecast the ... a CAGR of 32.12% over the period 2014-2019 ... devices in non-traditional sectors is one of the ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2
... Researchers working with rats have zeroed in on the ... behavior seen in users of cocaine as well as ... in such disorders as schizophrenia, depression, and post-traumatic stress ... A. Grace of the University of Pittsburgh described their ...
... rises during pregnancy, according to a study of women ... Johns Hopkins Bloomberg School of Public Health. The increased ... for behavior and other factors that contribute to HIV ... 30, 2005, edition of The Lancet, suggest that the ...
... puzzle in Alzheimer's disease (AD) research is why mice ... in humans show little pathology of the disease. Specifically, ... amyloid precursor protein (APP). It is this protein that, ... peptide that clusters into the amyloid plaque that clogs ...
Cached Biology News:New clue to cocaine addicts' quirky behavior 2Pregnant women at higher risk for HIV, Uganda study finds 2Pinpointing a culprit molecule in Alzheimer's disease 2
... 1 outflow Single-cell and patch delivery ... solution change Very small dead volume , ... 360, 250 and 100 micron delivery tips ... micromanipulator Available in 4, 8, and 16 ...
... are ideal for storage and transport of ... racks withstand extreme temperatures, making them an ... also be autoclaved for use in sterile ... accommodates 0.5ml microcentrifuge tubes, the other 1.5ml ...
... This kit consists of universal lysis ... control primers for 100 25 l volume ... types of Gram negative or positive rod ... Klebsiella Pneumoniae, Bacillus Cereus, Staphylococcus Aureus, Streptococcus ...
... optimized for serum-free growth of Ready-Plaque Sf9 ... medium, Sf9 cultures routinely reach densities greater ... above 95%. This medium is also recommended ... staining of pBACgus recombinants develops faster than ...
Biology Products: